Stay updated on JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.

Latest updates to the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page
- Check2 days agoChange DetectedNew site revision entry Revision: v3.6.5 has been added to the record history, replacing the previous Revision: v3.6.4 entry. This reflects an update to the platform's version in the history log.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new software revision label v3.6.4 was added to the history, replacing the prior v3.6.3. This reflects an internal update to the page version and does not change the study details or outcomes.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNew 'Study Status' appears in the record history, and the revision count updates to 47. An entry dated 2026-06-05 is removed.SummaryDifference0.2%

- Check37 days agoChange DetectedA new revision entry v3.6.3 has been added to the study record history, and the prior revision v3.6.2 has been removed. This indicates the history has advanced to a newer version of the record, reflecting an update to the documented record rather than changes to study content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history now includes Revision: v3.6.2 and no longer lists Revision: v3.6.0, reflecting an update to the page's versioning information.SummaryDifference0.1%

- Check59 days agoChange DetectedNew entries were added to the history: 'Check who can join' and 'Find Contact Information', and the record shows a revision to v3.6.0 replacing v3.5.5. These changes reflect updated eligibility access and contact details on the study page.SummaryDifference0.3%

Stay in the know with updates to JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.